Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 16,901 | 19,623 | 21,627 | 17,707 | 17,931 |
| Operating Income | -16,901 | -19,623 | -21,627 | -17,707 | -17,931 |
| Other Income | 22 | 1,202 | 5,203 | 11,235 | -6,593 |
| Pre-tax Income | -16,879 | -18,421 | -16,424 | -6,472 | -24,524 |
| Net Income Continuous | -16,879 | -18,421 | -16,424 | -6,472 | -24,524 |
| Net Income | $-16,879 | $-18,421 | $-16,424 | $-6,472 | $-24,524 |
| EPS Basic Total Ops | -16.00 | -17.60 | -15.80 | -6.40 | -27.80 |
| EPS Basic Continuous Ops | -16.01 | -17.55 | -15.72 | -6.42 | -27.72 |
| EPS Diluted Total Ops | -16.00 | -17.60 | -15.80 | -6.40 | -27.80 |
| EPS Diluted Continuous Ops | -16.01 | -17.55 | -15.72 | -6.42 | -27.72 |
| EBITDA(a) | $-16,722 | $-19,391 | $-21,397 | $-17,364 | $-17,883 |